TY - JOUR
T1 - Long-Acting Reversible Contraception
AU - Baker, Courtney C.
AU - Creinin, Mitchell D.
N1 - Publisher Copyright:
© 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Long-acting reversible contraceptive (LARC) methods are effective options for pregnancy prevention. Currently available products in the United States include an etonogestrel implant, a copper intrauterine device (IUD), and several levonorgestrel IUDs. With increasing prevalence and duration of use, our understanding of efficacy, risks, and benefits has evolved. In addition to a brief discussion on nomenclature and LARC use within a framework of bodily autonomy and reproductive justice, this review covers clinical challenges with placement and removal, evidence-based duration of use, and how to mitigate side effects. Although all obstetrician-gynecologists as well as primary care clinicians can safely provide LARCs, complex family planning specialists are an expert referral source for challenging cases and evidence-based care as contraceptive technology continues to develop.
AB - Long-acting reversible contraceptive (LARC) methods are effective options for pregnancy prevention. Currently available products in the United States include an etonogestrel implant, a copper intrauterine device (IUD), and several levonorgestrel IUDs. With increasing prevalence and duration of use, our understanding of efficacy, risks, and benefits has evolved. In addition to a brief discussion on nomenclature and LARC use within a framework of bodily autonomy and reproductive justice, this review covers clinical challenges with placement and removal, evidence-based duration of use, and how to mitigate side effects. Although all obstetrician-gynecologists as well as primary care clinicians can safely provide LARCs, complex family planning specialists are an expert referral source for challenging cases and evidence-based care as contraceptive technology continues to develop.
UR - http://www.scopus.com/inward/record.url?scp=85140416653&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140416653&partnerID=8YFLogxK
U2 - 10.1097/AOG.0000000000004967
DO - 10.1097/AOG.0000000000004967
M3 - Review article
C2 - 36201766
AN - SCOPUS:85140416653
SN - 0029-7844
VL - 140
SP - 883
EP - 897
JO - Obstetrics and gynecology
JF - Obstetrics and gynecology
IS - 5
ER -